Yann Mazabraud
Corporate Officer/Principal at RHYTHM PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-04-29
Yann Mazabraud active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-10-04 | - |
Career history of Yann Mazabraud
Former positions of Yann Mazabraud
| Companies | Position | Start | End |
|---|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 2017-10-31 | 2020-10-02 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2015-12-31 | 2017-09-30 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of Yann Mazabraud
| Groupe de Sup de Co La Rochelle | Graduate Degree |
Statistics
International
| United States | 4 |
| France | 2 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Yann Mazabraud
- Experience